Perrigo (PRGO) Exchange Rate Effect (2013 - 2026)
Perrigo (PRGO) posted quarterly Exchange Rate Effect of -$3.1 million for Q1 2026, down 130.1% year-over-year from $10.3 million in Q1 2025, and down 203.33% quarter-over-quarter from $3.0 million in Q4 2025.
Perrigo (PRGO) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Exchange Rate Effect for 14 consecutive years, with -$3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 130.1% year-over-year to -$3.1 million; the TTM figure through Mar 2026 stood at $19.1 million (up 453.7% YoY), while the FY2025 annual figure was $32.5 million, up 240.09% from the prior year.
- Exchange Rate Effect declined to -$3.1 million in Q1 2026 per PRGO's latest filing, from $3.0 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $19.0 million in Q2 2025 and bottomed at -$47.9 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$1.9 million across 5 years, with a median of $200000.0 in 2025.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 6942.86% — and 2025, when it surged 1004.76%.
- Perrigo's Exchange Rate Effect stood at $14.6 million in 2022, then dropped by 19.86% to $11.7 million in 2023, then slumped by 323.08% to -$26.1 million in 2024, then soared by 111.49% to $3.0 million in 2025, then plunged by 203.33% to -$3.1 million in 2026.
- Business Quant data shows PRGO's Exchange Rate Effect at -$3.1 million in Q1 2026, $3.0 million in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | -3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -3.00 Mn |
| Jun 27, 2026 | -3.00 Mn |
| Mar 28, 2026 | -3.10 Mn |
| Mar 28, 2026 | -3.10 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 27, 2025 | 200,000.00 |
| Sep 27, 2025 | 200,000.00 |
| Jun 28, 2025 | 19.00 Mn |
| Jun 28, 2025 | 19.00 Mn |
| Mar 29, 2025 | 10.30 Mn |
| Mar 29, 2025 | 10.30 Mn |
| Dec 31, 2024 | -26.10 Mn |
| Dec 31, 2024 | -26.10 Mn |
| Sep 28, 2024 | 12.50 Mn |
| Sep 28, 2024 | 12.50 Mn |
| Jun 29, 2024 | -2.10 Mn |
| Jun 29, 2024 | -2.10 Mn |
| Mar 30, 2024 | -7.50 Mn |
| Mar 30, 2024 | -7.50 Mn |